Zhaoke Ophthalmology-B (06622): Chen Yu resigns as non-executive director

Zhaoke Ophthalmology-B (06622) announced that Chen Yu has resigned as a non-executive director to spend more time on other work arrangements...

Zhitong FinanceApr 8 06:13 ET

Annual Report Observation: The second low-concentration atropine produced in China is coming, and the value of Zhaoke Ophthalmology-B (6622.HK) has been rediscovered

The innovative ophthalmology drug market has always been one of the hot areas that the market has paid great attention to, especially in the field of myopic ophthalmology.

Gelonghui FinanceApr 2 01:37 ET

Zhaoke Ophthalmological-B (06622.HK) announces annual results, first confirmation that sales revenue is continuing to expand its footprint globally

Gelonghui, March 27 | Zhaoke Ophthalmology-B (06622.HK) announced that the company first confirmed sales revenue in 2023: in 2023, the company recorded total revenue of RMB 18.8 million, of which RMB 4.7 million came from the sale of ophthalmic drugs (including bemesol timolol and Ruibault), while RMB 8.4 million came from the sale of non-prescription ophthalmic products (Baudexi series hot eye masks). Additionally, the company recorded revenue of RMB 5.6 million from distribution transaction payments outside of China. The company's pipeline is equipped with a variety of key innovative drugs that may have significant curative effects, which can be expected in the future

Gelonghui FinanceMar 27 06:48 ET

Zhaoke Ophthalmology-B (06622) announced annual results, net loss of 385 million yuan, a year-on-year decrease of 5.5%

Zhaoke Ophthalmology-B (06622) announced results for the year ended December 31, 2023, and the group achieved revenue...

Zhitong FinanceMar 27 06:38 ET

ZHAOKE OPHTH-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023

Futu NewsMar 27 06:30 ET · Announcements

Zhaoke Ophthalmology-B (06622.HK) held a board meeting on March 27 to consider and approve annual results

Gelonghui March 15 | Zhaoke Ophthalmology-B (06622.HK) announced that the board of directors meeting will be held on March 27, 2024 (Wednesday) to consider and approve (among other things) the annual results of the company and its subsidiaries for the year ended December 31, 2023 and their publication.

Gelonghui FinanceMar 15 05:32 ET